<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Hussain N</submitter><pubmed_abstract>The "Severe Acute Respiratory Syndrome" (SARS), which has relation to the coronavirus-2 considered to be a major cause of the disease addressed by COVID-19. COVID-19 requires the angiotensin converting enzyme 2 (ACE-2), which is considered to be the target receptor of the host cells. The intention of this practical research study was to observe ACE I/D polymorphism association with COVID-19 and also the &lt;i>in-silico&lt;/i> screening of potential phytochemicals against COVID-19. This study incorporated total of 320 blood samples; of which 160 were collected from COVID-19 patients and 160 were collected from healthy controls. DNA extraction was conducted from whole genomic blood and afterward, the banding patterns of ACE polymorphism were identified by the application of a nested polymerase cha</pubmed_abstract><journal>Bioinformatics and biology insights</journal><pagination>11779322221139061</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9760525</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Biological Causes and Consequences of COVID-19: ACE I/D Polymorphism and In-Silico Screening of Potential Bioactive Phytochemicals Against COVID-19.</pubmed_title><pmcid>PMC9760525</pmcid><pubmed_authors>Mumtaz M</pubmed_authors><pubmed_authors>Hussain N</pubmed_authors><pubmed_authors>Adil M</pubmed_authors><pubmed_authors>Waseem M</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Biological Causes and Consequences of COVID-19: ACE I/D Polymorphism and In-Silico Screening of Potential Bioactive Phytochemicals Against COVID-19.</name><description>The "Severe Acute Respiratory Syndrome" (SARS), which has relation to the coronavirus-2 considered to be a major cause of the disease addressed by COVID-19. COVID-19 requires the angiotensin converting enzyme 2 (ACE-2), which is considered to be the target receptor of the host cells. The intention of this practical research study was to observe ACE I/D polymorphism association with COVID-19 and also the &lt;i>in-silico&lt;/i> screening of potential phytochemicals against COVID-19. This study incorporated total of 320 blood samples; of which 160 were collected from COVID-19 patients and 160 were collected from healthy controls. DNA extraction was conducted from whole genomic blood and afterward, the banding patterns of ACE polymorphism were identified by the application of a nested polymerase cha</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-05T07:25:08.226Z</modification><creation>2024-11-09T10:37:14.522Z</creation></dates><accession>S-EPMC9760525</accession><cross_references><pubmed>36540330</pubmed><doi>10.1177/11779322221139061</doi></cross_references></HashMap>